Statement by FTC Chairman Jon Leibowitz Regarding Continuing Need for Legislation Banning Illegal Pay-for-Delay Drug Settlements

The Federal Trade Commission will continue working on behalf of Americans who are struggling to pay for their health care. According to our economic estimates, consumers would pocket about $3.5 billion a year if these unconscionable deals were stopped and they had earlier access to generic drugs.

It’s not a question of whether this should happen, but when.

President Obama is strongly behind a legislative provision banning anticompetitive settlements between branded and generic drug companies, and there is growing bipartisan support in the Congress for making such restrictions part of the United States’ national health care policy.

IR Press

Share
Published by
IR Press

Recent Posts

Testimony of Secretary of the Treasury Janet L. Yellen Before the Committee on Ways & Means, U.S. House of Representatives

As Prepared for DeliveryChairman Smith, Ranking Member Neal, and Members of the Committee: Thank you…

15 hours ago

Remarks by Under Secretary Brian Nelson at ACI’s Annual Flagship Conference on Economic Sanctions Enforcement and Compliance

As Prepared for DeliveryThank you very much to ACI for inviting me here today. I’m…

2 days ago

U.S. Department of the Treasury’s Federal Insurance Office Launches New Partnership with the National Science Foundation on Terrorism and Catastrophic Cyber Risks

WASHINGTON – This week, the U.S. Department of the Treasury’s Federal Insurance Office (FIO) hosted…

5 days ago

IRS Direct File Pilot Exceeds Usage Goal, Receiving Positive User Ratings and Saving Taxpayers Money

140,803 Taxpayers Filed Their Taxes Directly with the IRS for Free as users claimed more…

5 days ago

Acting Comptroller Issues Statement on the FDIC’s Proposals Related to Change in Bank Control Act

WASHINGTON—Acting Comptroller of the Currency Michael J. Hsu today issued the following statement at the…

5 days ago